Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Biancur DE"'
Autor:
Encarnación-Rosado J; Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY, USA.; Department of Radiation Oncology, New York University Grossman School of Medicine, New York, NY, USA., Sohn ASW; Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY, USA.; Department of Radiation Oncology, New York University Grossman School of Medicine, New York, NY, USA., Biancur DE; Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY, USA.; Department of Radiation Oncology, New York University Grossman School of Medicine, New York, NY, USA., Lin EY; Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY, USA.; Department of Radiation Oncology, New York University Grossman School of Medicine, New York, NY, USA., Osorio-Vasquez V; Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY, USA.; Department of Radiation Oncology, New York University Grossman School of Medicine, New York, NY, USA., Rodrick T; Division of Advanced Research Technologies, New York University School of Medicine, New York, NY, USA., González-Baerga D; Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY, USA.; Department of Radiation Oncology, New York University Grossman School of Medicine, New York, NY, USA., Zhao E; Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY, USA., Yokoyama Y; Dracen Pharmaceuticals, Inc., San Diego, CA, USA., Simeone DM; Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY, USA., Jones DR; Division of Advanced Research Technologies, New York University School of Medicine, New York, NY, USA., Parker SJ; Department of Biochemistry & Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada., Wild R; Dracen Pharmaceuticals, Inc., San Diego, CA, USA., Kimmelman AC; Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY, USA. Alec.Kimmelman@nyulangone.org.; Department of Radiation Oncology, New York University Grossman School of Medicine, New York, NY, USA. Alec.Kimmelman@nyulangone.org.
Publikováno v:
Nature cancer [Nat Cancer] 2024 Jan; Vol. 5 (1), pp. 85-99. Date of Electronic Publication: 2023 Oct 09.
Autor:
Kunjachan S, Detappe A, Kumar R, Ireland T, Cameron L, Biancur DE, Motto-Ros V, Sancey L, Sridhar S, Makrigiorgos GM, Berbeco RI
Publikováno v:
Nano letters [Nano Lett] 2022 Nov 23; Vol. 22 (22), pp. 9216. Date of Electronic Publication: 2022 Nov 02.
Autor:
Santana-Codina N; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Del Rey MQ; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Kapner KS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Zhang H; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Gikandi A; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Malcolm C; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Poupault C; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Kuljanin M; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., John KM; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Biancur DE; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Chen B; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan., Das NK; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan., Lowder KE; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Hennessey CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Huang W; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan., Yang A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Shah YM; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan., Nowak JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Mancias JD; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 Sep 02; Vol. 12 (9), pp. 2180-2197.
Autor:
Konieczny P; Department of Pathology, New York University Langone Health, New York, NY 10016, USA., Xing Y; Department of Pathology, New York University Langone Health, New York, NY 10016, USA., Sidhu I; Department of Pathology, New York University Langone Health, New York, NY 10016, USA.; Applied Bioinformatics Laboratory, New York University Langone Health, New York, NY 10016, USA., Subudhi I; Department of Pathology, New York University Langone Health, New York, NY 10016, USA., Mansfield KP; Department of Pathology, New York University Langone Health, New York, NY 10016, USA., Hsieh B; Department of Pathology, New York University Langone Health, New York, NY 10016, USA., Biancur DE; Department of Radiation Oncology and Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016, USA., Larsen SB; Neuroscience Institute, New York University Langone Health, New York, NY 10016, USA., Cammer M; Microscopy Laboratory, New York University Langone Health, New York, NY 10016, USA., Li D; Dermatology and Venereology Division, Department of Medicine, Solna Center for Molecular Medicine, Ming Wai Lau Centre for Reparative Medicine, Karolinska Institute, 17176 Stockholm, Sweden., Landén NX; Dermatology and Venereology Division, Department of Medicine, Solna Center for Molecular Medicine, Ming Wai Lau Centre for Reparative Medicine, Karolinska Institute, 17176 Stockholm, Sweden., Loomis C; Experimental Pathology Research Laboratory, New York University Langone Health, New York, NY 10016, USA., Heguy A; Genome Technology Center, New York University Langone Health, New York, NY 10016, USA., Tikhonova AN; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada., Tsirigos A; Department of Pathology, New York University Langone Health, New York, NY 10016, USA.; Applied Bioinformatics Laboratory, New York University Langone Health, New York, NY 10016, USA., Naik S; Department of Pathology, New York University Langone Health, New York, NY 10016, USA.; Department of Medicine, Ronald O. Perelman Department of Dermatology, and Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2022 Jul 08; Vol. 377 (6602), pp. eabg9302. Date of Electronic Publication: 2022 Jul 08.
Autor:
Banh RS; Department of Radiation Oncology, New York University Langone Health, New York, NY, USA.; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA., Kim ES; Department of Radiation Oncology, New York University Langone Health, New York, NY, USA.; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA., Spillier Q; Department of Radiation Oncology, New York University Langone Health, New York, NY, USA.; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA., Biancur DE; Department of Radiation Oncology, New York University Langone Health, New York, NY, USA.; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA., Yamamoto K; Department of Radiation Oncology, New York University Langone Health, New York, NY, USA.; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA., Sohn ASW; Department of Radiation Oncology, New York University Langone Health, New York, NY, USA.; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA., Shi G; Department of Radiation Oncology, New York University Langone Health, New York, NY, USA.; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA., Jones DR; Metabolomics Core Resource Laboratory, New York University Langone Health, New York, NY, USA., Kimmelman AC; Department of Radiation Oncology, New York University Langone Health, New York, NY, USA.; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA., Pacold ME; Department of Radiation Oncology, New York University Langone Health, New York, NY, USA. michael.pacold@nyulangone.org.; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA. michael.pacold@nyulangone.org.
Publikováno v:
Nature [Nature] 2021 Sep; Vol. 597 (7876), pp. 420-425. Date of Electronic Publication: 2021 Sep 01.
Autor:
Mukhopadhyay S; Laura and Isaac Perlmutter Cancer Center, Department of Radiation Oncology, New York University School of Medicine, New York, NY 10016., Biancur DE; Laura and Isaac Perlmutter Cancer Center, Department of Radiation Oncology, New York University School of Medicine, New York, NY 10016., Parker SJ; Laura and Isaac Perlmutter Cancer Center, Department of Radiation Oncology, New York University School of Medicine, New York, NY 10016., Yamamoto K; Laura and Isaac Perlmutter Cancer Center, Department of Radiation Oncology, New York University School of Medicine, New York, NY 10016., Banh RS; Laura and Isaac Perlmutter Cancer Center, Department of Radiation Oncology, New York University School of Medicine, New York, NY 10016., Paulo JA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115., Mancias JD; Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Kimmelman AC; Laura and Isaac Perlmutter Cancer Center, Department of Radiation Oncology, New York University School of Medicine, New York, NY 10016; alec.kimmelman@nyumc.org.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Feb 09; Vol. 118 (6).
Autor:
Biancur DE; Department of Radiation Oncology, Perlmutter Cancer Center, New York University Medical Center, New York, NY 10016, USA., Kapner KS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Yamamoto K; Department of Radiation Oncology, Perlmutter Cancer Center, New York University Medical Center, New York, NY 10016, USA., Banh RS; Department of Radiation Oncology, Perlmutter Cancer Center, New York University Medical Center, New York, NY 10016, USA., Neggers JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Sohn ASW; Department of Radiation Oncology, Perlmutter Cancer Center, New York University Medical Center, New York, NY 10016, USA., Wu W; Department of Pathology and Perlmutter Cancer Center, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA., Manguso RT; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Brown A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Root DE; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Medical School, Boston, MA 02115, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: andrew_aguirre@dfci.harvard.edu., Kimmelman AC; Department of Radiation Oncology, Perlmutter Cancer Center, New York University Medical Center, New York, NY 10016, USA. Electronic address: alec.kimmelman@nyulangone.org.
Publikováno v:
Cell metabolism [Cell Metab] 2021 Jan 05; Vol. 33 (1), pp. 199-210.e8. Date of Electronic Publication: 2020 Nov 04.
Autor:
Banh RS; Department of Radiation Oncology, Perlmutter Cancer Center, New York University Medical Center, New York, NY 10016, USA., Biancur DE; Department of Radiation Oncology, Perlmutter Cancer Center, New York University Medical Center, New York, NY 10016, USA., Yamamoto K; Department of Radiation Oncology, Perlmutter Cancer Center, New York University Medical Center, New York, NY 10016, USA., Sohn ASW; Department of Radiation Oncology, Perlmutter Cancer Center, New York University Medical Center, New York, NY 10016, USA., Walters B; Department of Microbiology and Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA., Kuljanin M; Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Hale Family Pancreatic Cancer Research Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Gikandi A; Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Hale Family Pancreatic Cancer Research Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Wang H; Department of Anatomical Pathology, M.D. Anderson Cancer Center, University of Texas, Houston, TX 77030, USA., Mancias JD; Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Hale Family Pancreatic Cancer Research Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Schneider RJ; Department of Radiation Oncology, Perlmutter Cancer Center, New York University Medical Center, New York, NY 10016, USA; Department of Microbiology and Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA., Pacold ME; Department of Radiation Oncology, Perlmutter Cancer Center, New York University Medical Center, New York, NY 10016, USA., Kimmelman AC; Department of Radiation Oncology, Perlmutter Cancer Center, New York University Medical Center, New York, NY 10016, USA. Electronic address: alec.kimmelman@nyulangone.org.
Publikováno v:
Cell [Cell] 2020 Nov 25; Vol. 183 (5), pp. 1202-1218.e25. Date of Electronic Publication: 2020 Nov 02.
Autor:
Kunjachan S, Detappe A, Kumar R, Ireland T, Cameron L, Biancur DE, Motto-Ros V, Sancey L, Sridhar S, Makrigiorgos GM, Berbeco RI
Publikováno v:
Nano letters [Nano Lett] 2020 Sep 09; Vol. 20 (9), pp. 6931. Date of Electronic Publication: 2020 Aug 10.
Autor:
Virani NA; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America., Kelada OJ; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America., Kunjachan S; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America., Detappe A; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston Massachusetts, United States of America., Kwon J; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Radiation Oncology, Hokkaido University, Sapporo, Japan., Hayashi J; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.; Nanomedicine Innovation Center and Department of Physics, Northeastern University, Boston, Massachusetts, United States of America., Vazquez-Pagan A; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.; Nanomedicine Innovation Center and Department of Physics, Northeastern University, Boston, Massachusetts, United States of America., Biancur DE; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston Massachusetts, United States of America., Ireland T; LA-ICP-MS and ICP-ES Laboratories, Boston University, Boston, Massachusetts, United States of America., Kumar R; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.; Nanomedicine Innovation Center and Department of Physics, Northeastern University, Boston, Massachusetts, United States of America., Sridhar S; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.; Nanomedicine Innovation Center and Department of Physics, Northeastern University, Boston, Massachusetts, United States of America., Makrigiorgos GM; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America., Berbeco RI; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.
Publikováno v:
PloS one [PLoS One] 2020 Jul 24; Vol. 15 (7), pp. e0236245. Date of Electronic Publication: 2020 Jul 24 (Print Publication: 2020).